Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Hero

Showing results (71-80 of 141) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97Barbara Hero, Thorsten Simon, Ruediger Spitz, et al.
The New England Journal of Medicine|April 5, 2002
Neuroblastoma screening at one year of ageFreimut H Schilling, Claudia Spix, Frank Berthold, et al.
Radiology. Imaging Cancer|December 12, 2025
Fractal Dimension of High-Risk Neuroblastoma Vascularity in MRI Is Associated with Chemotherapy Response and Event-Free SurvivalFlorian Michallek, Marc Dewey, Barbara Hero, et al.
The Lancet. Oncology|September 1, 2005
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trialFrank Berthold, Joachim Boos, Stefan Burdach, et al.
Pediatric Blood & Cancer|November 15, 2019
Biochemical testing for neuroblastoma using plasma free 3-O-methyldopa, 3-methoxytyramine, and normetanephrineMirko Peitzsch, Elizabeth R Butch, Elizabeth Lovorn, et al.
Cancer Immunology, Immunotherapy : CII|March 21, 2002
Ocular symptoms in children treated with human-mouse chimeric anti-GD2 mAb ch14.18 for neuroblastomaBernhard Kremens, Barbara Hero, Joachim Esser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Heterogeneity of the MYCN oncogene in neuroblastomaJessica Theissen, Marc Boensch, Ruediger Spitz, et al.
Genes, Chromosomes & Cancer|April 17, 2014
Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastomaJessica Theissen, Andre Oberthuer, Anja Hombach, et al.
International Journal of Cancer|January 12, 2012
Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastomaSimona Coco, Jessica Theissen, Paola Scaruffi, et al.
Journal of Pediatric Hematology/Oncology|November 15, 2017
Genomic Profiles of Neuroblastoma Associated With Opsoclonus Myoclonus SyndromeBarbara Hero, Nathalie Clement, Ingrid Øra, et al.
Pageof 15

Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97Barbara Hero, Thorsten Simon, Ruediger Spitz, et al.
The New England Journal of Medicine|April 5, 2002
Neuroblastoma screening at one year of ageFreimut H Schilling, Claudia Spix, Frank Berthold, et al.
Radiology. Imaging Cancer|December 12, 2025
Fractal Dimension of High-Risk Neuroblastoma Vascularity in MRI Is Associated with Chemotherapy Response and Event-Free SurvivalFlorian Michallek, Marc Dewey, Barbara Hero, et al.
The Lancet. Oncology|September 1, 2005
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trialFrank Berthold, Joachim Boos, Stefan Burdach, et al.
Pediatric Blood & Cancer|November 15, 2019
Biochemical testing for neuroblastoma using plasma free 3-O-methyldopa, 3-methoxytyramine, and normetanephrineMirko Peitzsch, Elizabeth R Butch, Elizabeth Lovorn, et al.
Cancer Immunology, Immunotherapy : CII|March 21, 2002
Ocular symptoms in children treated with human-mouse chimeric anti-GD2 mAb ch14.18 for neuroblastomaBernhard Kremens, Barbara Hero, Joachim Esser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Heterogeneity of the MYCN oncogene in neuroblastomaJessica Theissen, Marc Boensch, Ruediger Spitz, et al.
Genes, Chromosomes & Cancer|April 17, 2014
Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastomaJessica Theissen, Andre Oberthuer, Anja Hombach, et al.
International Journal of Cancer|January 12, 2012
Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastomaSimona Coco, Jessica Theissen, Paola Scaruffi, et al.
Journal of Pediatric Hematology/Oncology|November 15, 2017
Genomic Profiles of Neuroblastoma Associated With Opsoclonus Myoclonus SyndromeBarbara Hero, Nathalie Clement, Ingrid Øra, et al.
Pageof 15